- HMOX1 inducers
-
The present invention is related to compounds of structure (I) as heme oxygenase 1 (HMOX 1) inducers. The present invention is also related a method of controlling the activity or the amount, or both the activity and the amount, of heme-oxygenase 1 in a mammalian subject. The definitions of the variables are provided herein.
- -
-
Page/Page column 127
(2020/09/18)
-
- INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION
-
Sultam compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
- -
-
Paragraph 1806
(2020/03/01)
-
- QUINAZOLINE COMPOUND FOR EGFR INHIBITION
-
Disclosed is a novel quinazoline compound. Specifically, disclosed are a compound represented by the formula (I) and a pharmacologically acceptable salt.
- -
-
Paragraph 0210; 0212; 0222; 0224
(2019/11/21)
-
